{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:10:40Z","timestamp":1791220240070,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1097\/01.jcp.0000229483.52955.ec","type":"journal-article","created":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T05:58:34Z","timestamp":1153288714000},"page":"379-384","source":"Crossref","is-referenced-by-count":72,"title":["Increased Neuroactive Steroid Concentrations in Women With Bipolar Disorder or Major Depressive Disorder"],"prefix":"10.1097","volume":"26","author":[{"given":"Maria Carolina","family":"Hardoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Giovanni","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Contu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giuseppina","family":"Pisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Biggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.2422758","article-title":"Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.","volume":"232","author":"Majewska","year":"1986","journal-title":"Science"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2826.1995.tb00744.x","article-title":"Anxiolytic effect of progesterone is mediated by the neuroactive steroid allopregnanolone at brain GABAA receptors.","volume":"7","author":"Bitran","year":"1995","journal-title":"J Neuroendocrinol"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0074-7742(01)46064-8","article-title":"GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone.","volume":"46","author":"Biggio","year":"2001","journal-title":"Int Rev Neurobiol"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euroneuro.2003.08.002","article-title":"Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators.","volume":"13","author":"Biggio","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-0173(01)00109-6","article-title":"Biosynthesis and action of neuroactive steroids.","volume":"37","author":"Mellon","year":"2001","journal-title":"Brain Res Rev"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1523\/JNEUROSCI.22-09-03795.2002","article-title":"Stress-induced deoxycorticosterone-derived neuroactive steroids modulates GABAA receptor function and seizure susceptibility.","volume":"42","author":"Reddy","year":"2002","journal-title":"J Neurosci"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00006842-198312000-00004","article-title":"Mood, sexuality, hormones and the menstrual cycle: hormone levels and their relationship to the premenstrual syndrome.","volume":"45","author":"Backstrom","year":"1983","journal-title":"Psych Med"},{"key":"R8-6-20210128","first-page":"1256","article-title":"Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.","volume":"79","author":"Schmidt","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-6-20210128","first-page":"1076","article-title":"Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one.","volume":"81","author":"Wang","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0029-7844(97)00417-1","article-title":"Progesterone metabolite allopregnanolone in women with premenstrual syndrome.","volume":"l90","author":"Rapkin","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-978871","article-title":"Allopregnanolone in women with premenstrual syndrome.","volume":"30","author":"Bicikova","year":"1998","journal-title":"Horm Metab Res"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","article-title":"Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.","volume":"45","author":"Strohle","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.159.1.145","article-title":"GABAA receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.","volume":"159","author":"Strohle","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.60.2.161","article-title":"Induced panic attacks shift -aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.","volume":"60","author":"Strohle","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R15-6-20210128","first-page":"37","article-title":"Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3-21-dihydroxy-3-trifluoromethyl-19-nor-5-pregnan-20-one), a selective modulator of -aminobutyric acidA receptors.","volume":"295","author":"Vanover","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0006-3223(00)01044-1","article-title":"Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.","volume":"49","author":"Girdler","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00737-002-0147-1","article-title":"GABA receptors, progesterone and premenstrual dysphoric disorder.","volume":"6","author":"Sundstrom Poromaa","year":"2003","journal-title":"Arch Women Ment Health"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1615\/CritRevNeurobiol.v15.i34.20","article-title":"Pharmacology of endogenous neuroactive steroids.","volume":"15","author":"Reddy","year":"2003","journal-title":"Crit Rev Neurobiol"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1528-1157.2001.10100.x","article-title":"Neuroactive steroid withdrawal model of perimenstrual catamenial epilepsy.","volume":"42","author":"Reddy","year":"2001","journal-title":"Epilepsia"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1528-1157.2001.10200.x","article-title":"Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy.","volume":"42","author":"Reddy","year":"2001","journal-title":"Epilepsia"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.jcp.0000130552.78501.1a","article-title":"Long-term treatment with clozapine does not affect morning circulating levels of allopregnanolone and THDOC in patients with schizophrenia: a preliminary study.","volume":"24","author":"Monteleone","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effect of antidepressant treatment on neuroactive steroids in major depression.","volume":"155","author":"Romeo","year":"1998","journal-title":"Am J Psych"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/eje.0.1450025","article-title":"Neuroactive steroid-serotoninergic interaction: responses to an intravenous l-tryptophan challenge in woman with premenstrual dysphoric disorder.","volume":"145","author":"Rasgon","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1420269","article-title":"Allopregnanolone concentrations and premenstrual syndrome.","volume":"142","author":"Monteleone","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(03)00077-5","article-title":"Neurosteroid secretion in panic disorder.","volume":"118","author":"Brambilla","year":"2003","journal-title":"Psychiatry Res"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-6147(00)89058-6","article-title":"Neurosteroids and GABAA receptor function.","volume":"16","author":"Lambert","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(92)90454-F","article-title":"5-Pregnan-3-ol-20-one, a specific antagonist at the neurosteroid site of the GABAA receptor-complex.","volume":"135","author":"Prince","year":"1992","journal-title":"Neurosci Lett"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S0028-3908(00)00086-1","article-title":"Steroidogenesis in rat brain induced by short- and long-term administration carbamazepine.","volume":"39","author":"Serra","year":"2000","journal-title":"Neuropharmacology"},{"key":"R30-6-20210128","first-page":"135","article-title":"Premenstrual exacerbations of mood disorders.","volume":"35","author":"Miller","year":"2001","journal-title":"Psychopharmacol Bull"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0193-953X(03)00036-4","article-title":"Gender differences in bipolar disorder.","volume":"26","author":"Arnold","year":"2003","journal-title":"Psychiatr Clin North Am"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1176\/ajp.156.3.474","article-title":"Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features.","volume":"156","author":"Cassano","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.59.10.905","article-title":"Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder.","volume":"59","author":"Frank","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0165-0327(98)00158-X","article-title":"The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology.","volume":"54","author":"Cassano","year":"1999","journal-title":"J Affect Disord"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0193-953X(02)00025-4","article-title":"Conceptual underpinnings and empirical support for the mood spectrum.","volume":"25","author":"Cassano","year":"2000","journal-title":"Psychiatr Clin North Am"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1017\/S1121189X00007843","article-title":"A spectrum model for mood disorders: a useful approach in clinical psychiatry in search of an assessment methodology.","volume":"9","author":"Cassano","year":"2002","journal-title":"Epidemiol Psichiatr Soc"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1176\/appi.ajp.161.7.1264","article-title":"The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach.","volume":"161","author":"Cassano","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1021\/jm00168a008","article-title":"Synthesis, metabolism, and pharmacological activity of 3-hydroxy steroids which potentiate GABA receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes.","volume":"33","author":"Purdy","year":"1990","journal-title":"J Med Chem"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000126953","article-title":"Time dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress.","volume":"63","author":"Barbaccia","year":"1996","journal-title":"Neuroendocrinol"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0006-3223(94)91139-8","article-title":"CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI.","volume":"35","author":"George","year":"1994","journal-title":"Biol Psychiatry"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0893-133X(01)00254-8","article-title":"Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat.","volume":"25","author":"Barbaccia","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents.","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1073\/pnas.93.22.12599","article-title":"Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography.","volume":"93","author":"Uzunov","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s002130100853","article-title":"Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain.","volume":"158","author":"Serra","year":"2001","journal-title":"Psychopharmacology"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.lfs.2003.12.002","article-title":"Neurosteroids and neuroactive drugs in mental disorders.","volume":"74","author":"Pisu","year":"2004","journal-title":"Life Sci"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1210\/jcem.83.6.4905","article-title":"Circulating levels of allopregnanolone in humans: gender, age and endocrine influences.","volume":"83","author":"Genazzani","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000077934","article-title":"Plasma concentrations of anxiolytic neurosteroids in men with normal anxiety scores: a correlation analysis.","volume":"50","author":"Brambilla","year":"2004","journal-title":"Neuropsychobiology"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200608000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:43:23Z","timestamp":1785858203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200608000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000229483.52955.ec","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}